Cinepazide Maleate

马来酸桂哌齐特

Report date: 2023/02/13 15:15:47
NME

Base Information

Drug NameCinepazide Maleate
Drug Alias Name克林澳安捷利KelinaoAnjieliMD-67350 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsPeripheral Vascular DiseasesStrokeCerebrovascular Disorders
Global Approved IndicationsPeripheral Vascular DiseasesCerebrovascular Disorders
Approved Indications in ChinaPeripheral Vascular DiseasesCerebrovascular Disorders
Original Approved Country/TerritoryFrance
Original Approved Date1974/01/01
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sihuan Pharmaceutical Co LtdJilin Huikang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Vascular DiseasesStrokeCerebrovascular Disorders
Inactive IndicationsN/A

Other Information

ATC CodeC04AX27
Related LinksWikipedia